Additional file 1: of Data-driven identification of endophenotypes of Alzheimerâ s disease progression: implications for clinical trials and therapeutic interventions

  • Nophar Geifman (Contributor)
  • Richard E. Kennedy (Creator)
  • Lon S. Schneider (Creator)
  • Iain Buchan (Creator)
  • Roberta Brinton (Creator)
  • Lon S. Schneider (Creator)
  • Iain Buchan (Creator)



Full list of drug groups and search terms used to evaluate medication use at baseline (XLSX 42 kb)
Date made available2018

Cite this